By: Joseph Walker, Peter Loftus
President Trumps plan for new tariffs on pharmaceuticals landed like a bomb on social media late Thursday, but many of the worlds richest drugmakers
Joseph Walker is a Reporter at The Wall Street Journal. He covers a range of topics including pharmaceutical manufacturing, regulation, and consumer health, with a focus on the intersection of health and travel. Joseph's work has been featured in prominent publications such as The Globe and Mail, Reuters, and Yahoo Finance.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Joseph Walker's coverage is heavily focused on the health and healthcare industries, particularly regarding pharmaceutical companies, drug approvals, regulatory actions by government agencies like the FDA, and policy developments affecting drug prices. He has a specific focus on US-based news.
If you are reaching out to Joseph with a pitch or as a potential source, ensure that your expertise aligns with these areas of interest. Topics such as FDA approval processes for new drugs, investigations into health insurers' role in driving up drug costs, and industry responses to regulatory changes could be particularly relevant based on his recent articles.
Given his high percentage of press releases cited in coverage attributes (23%), providing access to exclusive data or insider perspectives related to major announcements from pharmaceutical companies or healthcare institutions may increase the likelihood of getting noticed by Joseph.
This information evolves through artificial intelligence and human feedback. Improve this profile .